By Maggie Fick and Sabrina Valle
Aug 5 (Reuters) - There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers.
"There is no deal between AstraZeneca and BMS. There never was a deal to be done, and there are no discussions between the companies," said the source, speaking on condition of anonymity.
AstraZeneca and Bristol Myers Squibb both declined to comment on emailed questions from Reuters.
AstraZeneca shares rose 2.9% on the Reuters report, while Bristol Myers Squibb shares were down 2.6% at 1341 GMT.
#astrazeneca #discussions
Aug 5 (Reuters) - There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers.
"There is no deal between AstraZeneca and BMS. There never was a deal to be done, and there are no discussions between the companies," said the source, speaking on condition of anonymity.
AstraZeneca and Bristol Myers Squibb both declined to comment on emailed questions from Reuters.
AstraZeneca shares rose 2.9% on the Reuters report, while Bristol Myers Squibb shares were down 2.6% at 1341 GMT.
#astrazeneca #discussions
27 days ago
